173 related articles for article (PubMed ID: 31897340)
1. Ribociclib-Related Stevens-Johnson Syndrome: Oncologic Awareness, Case Report, and Literature Review.
López-Gómez V; Yarza R; Muñoz-González H; Revilla E; Enrech S; González-Valle O; Tolosa P; Ciruelos E
J Breast Cancer; 2019 Dec; 22(4):661-666. PubMed ID: 31897340
[TBL] [Abstract][Full Text] [Related]
2. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
[TBL] [Abstract][Full Text] [Related]
3. Toxic epidermal necrolysis and Stevens-Johnson syndrome.
Harr T; French LE
Orphanet J Rare Dis; 2010 Dec; 5():39. PubMed ID: 21162721
[TBL] [Abstract][Full Text] [Related]
4. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
Hasegawa A; Abe R
F1000Res; 2020; 9():. PubMed ID: 32595945
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy patient with Stevens-Johnson Syndrome presents to the Emergency Department: A case report.
Widmer S; Grossman M
Am J Emerg Med; 2018 Jul; 36(7):1325.e3-1325.e4. PubMed ID: 29743141
[TBL] [Abstract][Full Text] [Related]
7. Study of Ocular Manifestations of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Abrol A; Gulanikar A; Thakre S; Patel A
Indian Dermatol Online J; 2020; 11(4):570-574. PubMed ID: 32832444
[TBL] [Abstract][Full Text] [Related]
8. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Era of Systems Medicine.
Chen CB; Wang CW; Chung WH
Methods Mol Biol; 2022; 2486():37-54. PubMed ID: 35437717
[TBL] [Abstract][Full Text] [Related]
9. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
[TBL] [Abstract][Full Text] [Related]
10. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up.
Lee HY; Walsh SA; Creamer D
Br J Dermatol; 2017 Oct; 177(4):924-935. PubMed ID: 28144971
[TBL] [Abstract][Full Text] [Related]
11. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit.
Houschyar KS; Tapking C; Borrelli MR; Nietzschmann I; Puladi B; Ooms M; Rein S; Houschyar M; Duscher D; Maan ZN; Reumuth G; Branski LK; Modabber A; Kluwig D; Schmitt L; Philipp-Dormston WG; Yazdi AS; Siemers F
J Wound Care; 2021 Jun; 30(6):492-496. PubMed ID: 34121430
[TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review.
Wong A; Malvestiti AA; Hafner Mde F
Rev Assoc Med Bras (1992); 2016; 62(5):468-73. PubMed ID: 27656858
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Treated Successfully with Oral Cyclosporin: Case report and literature review.
Al Rajaibi R; Al Rumhi T; Al Abri AM
Sultan Qaboos Univ Med J; 2021 Aug; 21(3):491-494. PubMed ID: 34522420
[TBL] [Abstract][Full Text] [Related]
14. Toxic epidermal necrolysis and Stevens-Johnson syndrome after COVID-19 infection and vaccination.
Zou H; Daveluy S
Australas J Dermatol; 2023 Feb; 64(1):e1-e10. PubMed ID: 36484649
[TBL] [Abstract][Full Text] [Related]
15. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
[TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.
Wang L; Varghese S; Bassir F; Lo YC; Ortega CA; Shah S; Blumenthal KG; Phillips EJ; Zhou L
Front Med (Lausanne); 2022; 9():949520. PubMed ID: 36091694
[TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
Ueta M
Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
[No Abstract] [Full Text] [Related]
18. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Fritsch PO; Sidoroff A
Am J Clin Dermatol; 2000; 1(6):349-60. PubMed ID: 11702611
[TBL] [Abstract][Full Text] [Related]
19. Dual Antiepileptics Induced Stevens-Johnson Syndrome: A Case Report.
Nakarmi P; Raut S; Manandhar S; Shrestha A
JNMA J Nepal Med Assoc; 2020 Oct; 58(230):801-804. PubMed ID: 34504362
[TBL] [Abstract][Full Text] [Related]
20. Oral lesions associated with Nevirapine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A report of 10 cases.
Reddy RB; Shekar PC; Chandra KL; Aravind R
J Oral Maxillofac Pathol; 2013 Sep; 17(3):431-5. PubMed ID: 24574667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
